ƒgƒbƒvƒy[ƒW  >  EVENTS  >  ΪΧ

EVENTS

discovery of stanniocalcin1 as cardiotoxic defence gene

                     

2024/04/25

We have discovered stanniocalcin1 as cardiotoxic defence gene in 2015. the potential clinical applications of stanniocalcin in oncocardiology include its use as a biomarker for cancer therapy-induced cardiotoxicity, its potential as a therapeutic target for cardioprotection, and its role in regulating calcium homeostasis, which may be relevant for managing calcium-related cardiovascular complications in cancer patients.

ŠΦ˜AƒŠƒ“ƒN

ŽOd‘εŠw‘εŠw‰@ˆγŠwŒnŒ€‹†‰ΘƒVƒXƒeƒ€ƒY–ς—Šw

ŽOd‘εŠwƒƒfƒBƒJƒ‹ƒ[ƒuƒ‰ƒtƒBƒbƒVƒ…Œ€‹†ƒZƒ“ƒ^[

ŠΦ˜Aƒtƒ@ƒCƒ‹

discovery of stanniocalcin1 as cardiotoxic defence gene

high-throughput screening for cardiotoxicology